Insights+: The US FDA New Drug Approvals in April 2023
May 17, 2023
Xbrane Biopharma Seeks to Initiate the Development of Keytruda and Darzalex Biosimilar
December 13, 2021
Merck Enters in Third Clinical Trial Collaboration with Adagene to Advance ADG106 + Keytruda (pembrolizumab) for Solid Tumors and...
August 19, 2021
Astellas and Seagen Report Updated Results of Padcev in Two Studies for Locally Advanced or Metastatic Urothelial Cancer Not Eligi...
May 21, 2021
Insights+: Breakthrough Therapy Designation by the US FDA in 2020
March 11, 2021
Merck's Keytruda (pembrolizumab) Receives the US FDA's Approval for Relapsed or Refractory Classical Hodgkin Lymphoma
October 16, 2020
Back to Home
Incisive News in 3 Shots.
First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
Terms of Service
Copyright © 2023 PharmaShots - All Rights Reserved.